Doglio et al. [47] treated SLE mice with anti-CD19 CAR Tregs, which efficiently inhibited the proliferation and activity of B cells in vitro, limited autoantibody production, and delayed lymphopenia without detectable toxicity in vivo. The gene discussed is CD19; the disease is systemic lupus erythematosus.